Seven- Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel

Harshman Lauren C.; Chen Yu-Hui; Liu Glenn; Carducci Michael A.; Jarrard David; Dreicer Robert; Hahn Noah; Garcia Jorge A.; Hussain Maha; Shevrin Daniel; Eisenberger Mario; Kohli Manish; Plimack Elizabeth R.; Cooney Matthew; Vogelzang Nicholas J.; Picus Joel; Dipaola Robert; Sweeney Christopher J.

首页> 外文期刊>Journal of Clinical Oncology >Seven- Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel

【24h】

Seven- Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel

机译：七个月的前列腺特异性抗原在用雄激素剥夺治疗的转移性激素敏感前列腺癌预后，或没有多西紫杉醇治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2018年第4期|共10页
作者
Harshman Lauren C.; Chen Yu-Hui; Liu Glenn; Carducci Michael A.; Jarrard David; Dreicer Robert; Hahn Noah; Garcia Jorge A.; Hussain Maha; Shevrin Daniel; Eisenberger Mario; Kohli Manish; Plimack Elizabeth R.; Cooney Matthew; Vogelzang Nicholas J.; Picus Joel; Dipaola Robert; Sweeney Christopher J.;
展开▼
作者单位

Harvard Med Sch Dana Farber Canc Inst Boston MA USA;

Dana Farber Canc Inst Eastern Cooperat Oncol Grp Amer Coll Radiol Imaging Network Canc Res Grp;

Univ Wisconsin Sch Med &

Publ Hlth Madison WI USA;

Johns Hopkins Univ Baltimore MD USA;

Univ Wisconsin Sch Med &

Publ Hlth Madison WI USA;

Univ Virginia Ctr Canc Charlottesville VA 22908 USA;

Johns Hopkins Univ Baltimore MD USA;

Cleveland Clin Taussig Canc Inst Cleveland OH 44106 USA;

Northwestern Univ Feinberg Sch Med Robert H Lurie Comprehens Canc Ctr Chicago IL 60611 USA;

NorthShore Univ Hlth Syst Evanston IL USA;

Johns Hopkins Univ Baltimore MD USA;

Mayo Clin Rochester MN USA;

Temple Hlth Fox Chase Canc Ctr Philadelphia PA USA;

Univ Hosp Cleveland Med Ctr Seidman Canc Ctr Cleveland OH 44106 USA;

Comprehens Canc Ctr Nevada Las Vegas NV USA;

Washington Univ Sch Med Siteman Canc Ctr St Louis MO USA;

Rutgers Canc Inst New Jersey New Brunswick NJ USA;

Harvard Med Sch Dana Farber Canc Inst Boston MA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Seven- Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel [J] . Harshman Lauren C., Chen Yu-Hui, Liu Glenn, Journal of Clinical Oncology . 2018,第4期

机译：七个月的前列腺特异性抗原在用雄激素剥夺治疗的转移性激素敏感前列腺癌预后，或没有多西紫杉醇治疗
2. Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer. [J] . Taplin ME, Xie W, Bubley GJ, Journal of Clinical Oncology . 2006,第34期

机译：明确的前列腺癌局部治疗后，对于具有前列腺特异性抗原进展的男性，多西他赛，雌莫司汀和15个月雄激素被剥夺。
3. Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer. [J] . Taplin ME, Xie W, Bubley GJ, Journal of Clinical Oncology . 2006,第34期

机译：明确的前列腺癌局部治疗后，对于具有前列腺特异性抗原进展的男性，多西他赛，雌莫司汀和15个月雄激素被剥夺。
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. Cost and Management of Fractures in Medicare Beneficiaries with Non-Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy. [D] . Yong, Candice Yuk Chen. 2015

机译：用雄激素剥夺疗法治疗的非转移性前列腺癌医疗保险受益人骨折的成本和管理。
6. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel [O] . Lauren C. Harshman, Yu-Hui Chen, Glenn Liu, -1

机译：前列腺素特异性抗原七个月在转移性激素敏感型前列腺癌的预后中该雄激素剥夺性有或无多西他赛治疗
7. Cost-effectiveness analysis of additional docetaxel for metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy from a Chinese perspective [O] . H.R. Zheng, F. Wen, Y.F. Wu, 2016

机译：中国视角下雄激素剥夺疗法治疗转移激素敏感前列腺癌的额外多西紫杉醇的成本效果分析

Seven- Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel

摘要

著录项

相似文献

相关主题

期刊订阅